Skip to main content

Table 2 Genotypic distribution of KLF SNPs in type 2 diabetic and non-diabetic individuals

From: Analysis of KLFtranscription factor family gene variants in type 2 diabetes

dbSNP ID N/M MAF D1/C1 P-value MAF D2/C2 P-value MAF D/C P-value
KLF2, Chr. 19q13 0.31 (167, 142, 34) 0.69     
Prom -789 C/T 0.32 (148, 143, 30)      
rs10424657 G/A 0.30 (175, 146, 34) 0.61     
   0.31 (162, 155, 32)      
rs12459387 C/T 0.09 (292, 58, 4) 0.09 0.10 (464, 106, 6) 0.87 0.10 (756, 164, 10) 0.40
   0.12 (260, 78, 2)   0.10 (543, 123, 6)   0.11 (803, 201, 8)  
rs7248864 C/T 0.09 (295, 56, 5) 0.13     
   0.12 (270, 78, 2)      
rs3745318 C/T 0.21 (211, 109, 16) 0.67     
   0.20 (214, 114, 11)      
rs12462380 A/G 0.41 (119, 178, 56) 0.24     
   0.44 (102, 170, 63)      
rs7258799 A/T 0.13 (277, 81, 6) 0.15     
   0.16 (219, 74, 10)      
rs15336 C/A 0.19 (235, 111, 12) 0.21     
   0.16 (235, 94, 8)      
rs11086029 A/T 0.22 (209, 121, 14) 0.63     
   0.21 (217, 117, 13)      
KLF3, Chr. 4q14 0.44 (110, 180, 70) 0.89     
rs2045767 G/T 0.45 (105, 182, 68)      
rs9522 C/T 0.45 (110, 171, 75) 0.62     
   0.46 (97, 178, 72)      
KLF4, Chr. 9q31 0.47 (97, 174, 79) 0.08 0.49 (144, 297, 133) 0.68 0.48 (241, 471, 212) 0.08
rs10759240 C/A 0.52 (80, 168, 95)   0.51 (176, 361, 187)   0.51 (256, 529, 282)  
KLF5, Chr. 13q21 0.16 (248, 97, 6) 0.67     
rs12428414 C/T 0.16 (237, 88, 11)      
rs4885065 A/G 0.17 (245, 94, 11) 0.83     
   0.16 (247, 98, 8)      
rs9564944 A/G 0.12 (263, 69, 5) 0.90     
   0.12 (269, 62, 8)      
rs11841945 C/G 0.46 (94, 173, 65) 0.04 0.42 (200, 271, 110) 0.20 0.43 (294, 444, 175) 0.91
   0.40 (110, 145, 48)   0.45 (227, 349, 151)   0.43 (337, 494, 199)  
KLF6, Chr. 10p15 0.11 (290, 68, 5) 0.63     
rs7005 C/T 0.12 (281, 66, 8)      
KLF12, Chr. 13q21 0.36 (148, 164, 47) 0.36     
rs1927010 A/T 0.32 (154, 162, 38)      
rs4885151 G/T 0.31 (165, 166, 31) 0.80     
   0.32 (169, 144, 42)      
rs7993625 C/T 0.24 (205, 128, 21) 0.60     
   0.23 (199, 133, 12)      
rs6650443 A/G 0.19 (245, 99, 19) 0.66     
   0.20 (224, 107, 15)      
rs9600167 C/G 0.35 (154, 158, 46) 0.49     
   0.23 (160, 141, 44)      
KLF13, Chr. 15q12 0.44 (120, 169, 74) 0.71     
rs11855557 A/G 0.45 (102, 189, 64)      
rs12592176 G/A 0.50 (84, 186, 83) 0.49     
   0.48 (98, 172, 84)      
rs4779516 T/C 0.44 (115, 175, 70) 0.36     
   0.46 (96, 187, 69)      
KLF15, Chr. 3q13 0.12 (268, 74, 4) 0.35     
3'UTR+244del(CACGAAGG) 0.10 (285, 58, 7)      
KLF16, Chr. 19q13 0.47 (100, 162, 79) 0.11     
rs11670146 A/G 0.47 (101, 144, 56)      
rs3746045 T/C 0.24 (208, 120, 24) 0.23     
   0.21 (214, 119, 14)      
  1. D, type 2 diabetic patients; C, non-diabetic individuals; MAF, minor allele frequency; (number of subjects with wild type homozygote; heterozygote; mutant homozygote alleles); P-value for differences between allele frequencies under an allelic model.